Why do cells and tissues age and what are the genetic and molecular causes for aging? These are the central research questions that Italian junior scientist Dr. Francesco Neri, PhD, is trying to answer. Currently starting his own research group at Leibniz Institute on Aging (FLI) in Jena, Germany, Neri will be awarded the Sofja Kovalevskaja Award of the Alexander von Humboldt Foundation in November 2016 – one of the most highly endowed research awards in Germany.
In recent times, our understanding of aging has deeply changed. Stem cells, that are the basis for organ regeneration throughout life, start to mutate in genetic regions that regulate the epigenome, i.e. the surface and structure of our genetic information.
Francesco Neri, Junior Group Leader of the research group on “Epigenetics of Aging“ at Leibniz Institute on Aging (FLI) in Jena.
Photo: Evelyn Kästner / FLI
These mutants become clonal, increasing the risk of disease and death. Roughly half of mankind aged 70 is affected by these alterations. Italian researcher Francesco Neri investigates the fundamentals of these processes and is now awarded the Sofja Kovalevskaja Award of the Alexander von Humboldt Foundation, one of the most highly endowed research awards in Germany.
He is one out of six international young scientists from the USA, Poland/Canada, Italy, Kenia, USA/Denmark and Iran/Australia who get the opportunity to build up their own research focus and research group at a German research institute – funded by up to 1.65 million Euro each. The awards will be given to the prizewinners on November 15, 2016, in Berlin.
Big Chance for a Young Scientist
“The Sofja Kovalevskaja Award provides young researchers with a great opportunity to follow their creative research approaches on a nearly independent basis“, Prof. Dr. Karl Lenhard Rudolph, Scientific Director of Leibniz Institute on Aging (FLI), emphasizes the importance of the research award. The funding of the Alexander von Humboldt Foundation enables Francesco Neri to build up a new junior research group on “Epigenetics of Aging“ at the Institute in Jena.
The new group is focusing on the functional characterization of epigenetic alterations associated to stem cell aging. Research aims at describing these epigenetic changes and how they are selectively accumulated over the years, e.g. altered methylation patterns of the DNA. Furthermore, the research focuses on the understanding of why and how aging-associated epigenetic alterations impact stem cell function and lead to a clonal dominance and cancer development.
“I’m really happy about this prestigious award”, Dr. Neri proudly explains. “As an internationally renowned research institute in the area of aging research, the FLI offers me an optimal research environment which enables me to fully concentrate on my own research focus.”
The Laureate – Francesco Neri
Dr. Francesco Neri was born in Italy in 1981. He studied molecular biology and gained his PhD in biotechnology at the University of Siena. After a period of research at Radboud University Medical Centre in Nijmegen, Netherlands, he returned to Italy, doing postdoctoral research at the Human Genetics Foundation in Torino, where he became a research assistant in 2015. Since July 2016, Dr. Neri has been heading a junior research group at FLI.
Sofja Kovalevskaja Award for Young Promising Scientists
The Alexander von Humboldt Foundation’s Sofja Kovalevskaja Award is named after the Russian mathematician Sofja Kovalevskaja and is one of the most highly endowed research awards in Germany. Funded by the Federal Ministry of Education and Research, it is granted to young exceptionally promising researchers from abroad in recognition of outstanding academic achievements. The award is designed to enable them to embark on academic careers in Germany by establishing their own junior research groups at research institutions in Germany. The Kovalevskaja Award is endowed with up to 1.65 million Euros.
More information on the award and the awarding ceremony can be found on http://www.humboldt-foundation.de/web/start.html.
Dr. Evelyn Kästner
Leibniz Institute on Aging – Fritz Lipmann Institute (FLI), Beutenbergstr. 11, 07745 Jena, Germany
Tel.: 03641-656373, Fax: 03641-656351
The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) is the first German research organization dedicated to biomedical aging research since 2004. More than 330 members from over 30 nations explore the molecular mechanisms underlying aging processes and age-associated diseases. For more information, please visit http://www.leibniz-fli.de.
The Leibniz Association connects 88 independent research institutions that range in focus from the natural, engineering and environmental sciences via economics, spatial and social sciences to the humanities. Leibniz Institutes address issues of social, economic and ecological relevance. They conduct knowledge-driven and applied basic research, maintain scientific infrastructure and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer to policy-makers, academia, business and the public. Leibniz Institutes collaborate intensively with universities – in the form of “WissenschaftsCampi” (thematic partnerships between university and non-university research institutes), for example – as well as with industry and other partners at home and abroad. They are subject to an independent evaluation procedure that is unparalleled in its transparency. Due to the institutes’ importance for the country as a whole, they are funded jointly by the Federation and the Länder, employing some 18,100 individuals, including 9,200 researchers. The entire budget of all the institutes is approximately 1.64 billion EUR. See http://www.leibniz-association.eu for more information.
http://www.leibniz-fli.de - Website Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Jena
Dr. Kerstin Wagner | idw - Informationsdienst Wissenschaft
Innovation Award of the United Nations Environment Programme for PhD Student from ZMT
22.03.2018 | Leibniz-Zentrum für Marine Tropenforschung (ZMT)
ERC Project set to boost application of adhesive structures
19.03.2018 | INM - Leibniz-Institut für Neue Materialien gGmbH
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy